It is imperative to consider the potential life-saving benefits of IVC ligation despite the higher incidence of associated complications.

At ESMO 2024, Bayer will present key results from the Phase III ARANOTE trial on NUBEQA® (darolutamide) for metastatic hormone-sensitive prostate cancer and the PEACE-III study of XOFIGO® (radium-223) ...

At UCL, every PhD student is affiliated to a Centre for Doctoral Training (CDT) that is responsible for their pastoral care and co-curricular activities. In our department, you have the choice between ...